Q3 2024 Earnings Call Nov 06, 2024, 4:30 p.m. ET. Contents: Prepared Remarks. Questions and Answers. Call Participants.

For more information on Gilead Sciences, please visit the company’s website at www.gilead.com, follow Gilead on Twitter ...

Q3 2024 Earnings Conference Call November 6, 2024 4:30 PM ETCompany ParticipantsDaniel O'Day - Chairman, Chief ...

Gilead Sciences, Inc. (NASDAQ:GILD ... The press release, slides and supplementary data are available on the Investors section of our website at gilead.com. The speakers on today's call will be our ...

Presentation Operator Good afternoon, everyone, and welcome to Gilead's Third Quarter 2024 Earnings Conference Call. My name ...

Gilead Sciences, Inc. today presented the first in-depth look at full results from its pivotal Phase 3 PURPOSE 2 trial (NCT04925752), which is studying twice-yearly lenacapavir, the company's ...

Scottish Medicines Consortium Accepts Kite CAR T-Cell Therapy for Earlier Use to Treat Aggressive Blood Cancers - First SMC acceptance of any CAR T-cell therapy for lymphoma patients in the ...

All presentations and supplemental materials will be available under the Investor Relations section of Aviat's website following the event. Gilead Sciences, Inc. announced today that its executives ...

Susie was born Susan Summerall, as one of three children of Pat Summerall and his wife Kathy Summerall. Pat played football ...

Wiles is co-chair at lobbying firm Mercury Public Affairs and has represented clients in the tobacco, junk food, insurance, ...

Trump’s newly named WH chief of staff Susie Wiles retained her position as co-chair of the lobbying firm Mercury Public ...

The global hepatitis B diagnostic tests market is on the cusp of substantial expansion, driven by a combination of increasing disease incidence, heightened global awareness campaigns, and rapid ...